Trending...
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- Some Music for Donald's Bad Day
GROSSE POINTE, Mich. - Michimich -- SciTech Development announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Earle Holsapple, President will be presenting SciTech's innovative ST-001 nanoFenretinide technology at Biotech Showcase as follows:
Date: Monday, January 13, 2020
Time: 11:15 AM (PST)
Room: Franciscan B
Venue: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco, CA
Qualified investors can register to attend Biotech Showcase for free.
ST-001 nanoFenretinide is a small-molecule cancer drug comprised of nanoparticle sized fenretinide in a patented combination with carefully selected phospholipids. SciTech's product pipeline includes nanoFenretinide formulations for the treatment for several cancer indications. The FDA has granted Orphan Drug Status for ST-001 nanoFenretinide in the treatment of two types of NHL: peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL).
More on Michimich.com
About SciTech Development
SciTech Development, LLC is a clinical stage oncology drug company currently bringing to market a proven cancer drug for diseases with otherwise limited therapeutic options. SciTech Development is headquartered in the Metropolitan Detroit Michigan Area with laboratories at the Sinai Hospital BioIncubator in Baltimore Maryland. Information regarding SciTech's nano formulation technology and oncology drug product ST-001 nanoFenretinide is available from SciTech Development, LLC by calling (313) 938-5517 or at https://www.scitechdevelopment.com/ . You can follow SciTech Development on Twitter at @SciTechUSA
About Biotech Showcase
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
More on Michimich.com
Forward-Looking Information
This press release and linked information contains forward-looking statements, including information about management's view of SciTech Development LLC ("the Company"), future expectations, plans and prospects. Any statements made in this release and linked information other than those of historical fact, about an action, event or development, are forward-looking statements. The forward-looking statements included in this press release and linked information are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by SciTech Development LLC.
Date: Monday, January 13, 2020
Time: 11:15 AM (PST)
Room: Franciscan B
Venue: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco, CA
Qualified investors can register to attend Biotech Showcase for free.
ST-001 nanoFenretinide is a small-molecule cancer drug comprised of nanoparticle sized fenretinide in a patented combination with carefully selected phospholipids. SciTech's product pipeline includes nanoFenretinide formulations for the treatment for several cancer indications. The FDA has granted Orphan Drug Status for ST-001 nanoFenretinide in the treatment of two types of NHL: peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL).
More on Michimich.com
- Matthew Cossolotto, Author of The Joy of Public Speaking, Appears on "Get Authentic with Marques Ogden" and "Achieving Success with Olivia Atkin"
- CCHR Exposes Conflicted Psychiatrists Behind Teen Antidepressant Surge
- WIBO Announces Fall 2025 Entrepreneurship Programs to Empower NYC Founders and Small Business Owners
- Local College Student Launches "Cleopatra" App to Make Cleaning Easy for Mercer County Residents
- Wohler announces release of additional Balance Control output tracking for its eSeries in-rack monitor range
About SciTech Development
SciTech Development, LLC is a clinical stage oncology drug company currently bringing to market a proven cancer drug for diseases with otherwise limited therapeutic options. SciTech Development is headquartered in the Metropolitan Detroit Michigan Area with laboratories at the Sinai Hospital BioIncubator in Baltimore Maryland. Information regarding SciTech's nano formulation technology and oncology drug product ST-001 nanoFenretinide is available from SciTech Development, LLC by calling (313) 938-5517 or at https://www.scitechdevelopment.com/ . You can follow SciTech Development on Twitter at @SciTechUSA
About Biotech Showcase
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
More on Michimich.com
- Bavarian Blast Waterpark Announces Season Passes
- A Milestone of Giving: Ten Percent Group Donates £25,000 to Cure Parkinson's
- Tami Goveia Enters FabOver40, Inspiring Hollywood Legacy for Breast Cancer Cause
- Sterling Heights: Looking Local: Five Must-Try Favorites at Choco Mania Cafe
- Looking Local: Hug Baan Thai Creates a Cozy Escape in Sterling Heights
Forward-Looking Information
This press release and linked information contains forward-looking statements, including information about management's view of SciTech Development LLC ("the Company"), future expectations, plans and prospects. Any statements made in this release and linked information other than those of historical fact, about an action, event or development, are forward-looking statements. The forward-looking statements included in this press release and linked information are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by SciTech Development LLC.
Contact
Earle Holsapple
Tel: +1-313-938-5517 Email: eth@scitechdevelopment.com
***@scitechdevelopment.com
Earle Holsapple
Tel: +1-313-938-5517 Email: eth@scitechdevelopment.com
***@scitechdevelopment.com
Source: SciTech Development, LLC
0 Comments
Latest on Michimich.com
- America Anesthesia Partners Unveils New User-Friendly Website
- Hiclean Tools Releases HCX2100 Electric Pressure Washer
- Bùng Nổ Ra Mắt, AALIVE Tung Gói Thưởng 68% và Dàn Game Thuần Việt Hấp Dẫn
- ARCH Dental + Aesthetics Offers Free Consultations for New Patients
- Maisano Brothers Inc. Expands National Paving Division Into Tampa, Florida
- Multi-Signature Cold Storage: Keyanb Introduces Institutional-Grade Asset Protection for Chilean Crypto Traders
- NKSCX Introduces Zero-Knowledge Proof of Solvency for U.S. Traders Amid $6.5 Billion Fraud Crisis
- New Oasis International Foundation Announces Strategic Partnership Network Across 15 Countries to Advance Community-Led Economic Development
- Some Music for Donald's Bad Day
- New You Smile Dental Implant Center Expands Office
- $8 Billion High-Margin National Gentlemen's Club Market Targeted by Acquisition Strategy Incorporating the Successful Peppermint Hippo™ Brand: $TRWD
- Why Indian Game Development Companies Are Shaping the Future of Global Gaming
- Cold Storage and Proof-of-Reserves: BTXSGG Launches Institutional-Grade Asset Protection for Filipino Traders
- CGT Highlights Strategic Advantages of Nitrogen Generators for Large-Scale Food Manufacturers
- Why FIRE Enthusiasts Are Buying Businesses Instead of Just Saving Their Way to Freedom
- All About bail Bonds Expands Presence to Serve Houston Families
- Thousands to Ride to L.A. Children's Hospital This Halloween Night
- Essential Living Support Opens First VA Medical Foster Home in Cheyenne, Wyoming
- Six-Figure Chicks Book Series 96 Authors, 6 Volumes Published to Empower and Mentor Women Nationwide
- LSC Destruction Launches Cutting-Edge Cryptocurrency Scanning to Hard Drive Destruction Services